ArticleCancer research communications2025

MYC and HSF1 Cooperate to Drive Sensitivity to Polo-like Kinase 1 Inhibitor Volasertib in High-grade Serous Ovarian Cancer.

Imade Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.